fda warning letters compounded semaglutide 2025 september There's lots going on this month at in the world of weight loss drugs. The agency is taking a hard look at the market. Check out these new #FDA Concerns Surrounding Compounded GLP-1s Mount
Description
Wang, C., and D
What makes retatrutide dosing unique compared to older drugs
Alhadeff AL, Mergler BD, Zimmer DJ, Turner CA, Reiner DJ, Schmidt HD et al
Patients with certain GLP1R rs6923761 genotypes may experience more pronounced nausea during early titration, allowing your provider to recommend slower dose escalation or prophylactic anti-nausea support upfront
Gjolberg, T
But for those already dealing with significant exercise tolerance issues and muscle-related symptoms, its another variable to be aware of
